No Data
No Data
Guolian Securities: Increased attention to tumor immunology, recommend focusing on targeted drugs such as PD1/IL2 in pharmaceutical companies.
With the increasing attention to tumor immunity, and the successive launch of advantageous products, bullish on PD1/IL2 and PD1/IL15 targeted drugs.
Hang Seng Index: Benefiting from policy support, biotechnology stocks have seen three consecutive months of inflows.
The Hang Seng Index company stated that there are signs of improvement in the recent situation of biotechnology stocks, as well as benefitting from policy support and three consecutive months of inflow of funds.
Tigermed (300347.SZ): has repurchased a total of 3.6552 million shares.
On August 5th, Gelon Wenhui reported that, as of July 31, 2024, Tigermed (300347.SZ) had repurchased a cumulative total of 3,655,200 shares of the company through centralized competitive bidding for the company's stock repurchase special securities account, accounting for 0.4226% of the total share capital and 0.4927% of the total A-share capital of the company. The highest fill price was 55.30 yuan/share, the lowest fill price was 48.17 yuan/share, and the total trade amount was 191146104.89 yuan (excluding trading fees).
Hangzhou Tigermed Consulting Co., Ltd's (SZSE:300347) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Abnormal movement hits | CRO concept stocks lead the gains, the Fed's interest rate cuts will be bullish for CXO enterprise customers, and Shanghai issued a document supporting biomedical innovation.
On August 2nd, CRO concept stocks rose in early trading. As of press time, Tigermed (03347.HK) rose 5.67%, reporting 31.7 Hong Kong dollars; WuXi AppTec (02359.HK) rose 4.60%, reporting 33 Hong Kong dollars; Joinn Laboratories (06127.HK) rose 3.85%, reporting 7.56 Hong Kong dollars; Pharmaron (03759.HK) rose 3.80%, reporting 9.84 Hong Kong dollars. Market source: Futubull. On the news front, the Federal Reserve stated that if progress in combating inflation continues as desired, it may announce interest rate cuts at its September meeting. There are
CRO concept stocks rose, with Tigermed (03347) and MediTrust (02158) soaring.
According to Zhitong Finance APP, CRO concept stocks continued to rise in the afternoon. As of press time, Tigermed (03347) rose 7.78% to HKD 29.80, WuXi AppTec (02359) rose 7.54% to HKD 32.10, and iCarbonX (02158) rose 4.40% to HKD 3.56.
No Data